MARKET

CLB

CLB

Core Laboratories N V
NYSE

Real-time Quotes | Nasdaq Last Sale

19.83
+0.02
+0.10%
After Hours: 19.83 0 0.00% 16:03 07/01 EDT
OPEN
19.97
PREV CLOSE
19.81
HIGH
20.27
LOW
18.65
VOLUME
308.19K
TURNOVER
0
52 WEEK HIGH
40.97
52 WEEK LOW
18.41
MARKET CAP
918.62M
P/E (TTM)
95.80
1D
5D
1M
3M
1Y
5Y
CORE LABORATORIES' SECOND QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON JULY 28, 2022
Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its second quarter 2022 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on July 28, 2022.
PR Newswire · 4d ago
Is it a Great Move to Invest in Core Laboratories (CLB)?
Harding Loevner, an investment management firm, published its “International Small Companies Equity Fund” first-quarter 2022 investor letter – a copy of which can be downloaded here. The International Small Companies composite declined 13.4% gross of fees ...
Insider Monkey · 06/23 13:50
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 329 companies hit new 52-week lows.
Benzinga · 06/22 16:30
Bears are attacking leaders; MKM says these energy stocks are at risk
No sector is safe in bear markets and the current selling of winning stocks is typical of the later innings of market declines, MKM Partners says. "The high degree of
Seekingalpha · 06/21 16:08
Sector Update: Energy
MT Newswires · 06/09 13:09
Core Laboratories launches $60M at-the-market equity offering program
Core Laboratories (NYSE:CLB) has launched a $60M at-the-market equity offering program. The company plans to sell its common shares having an aggregate sales price of up to $60M as part
Seekingalpha · 06/09 12:25
BRIEF-Core Lab Announces $60 Mln At-The-Market Equity Offering Program
reuters.com · 06/09 12:20
CORE LAB ANNOUNCES $60,000,000 AT-THE-MARKET EQUITY OFFERING PROGRAM
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core," "Core Lab," or the "Company") announced today that it has established an at-the-market equity offering program (the "ATM Program") under which it may, from time to time, sell...
PR Newswire · 06/09 12:17
More
No Data
Learn about the latest financial forecast of CLB. Analyze the recent business situations of Core Laboratories N V through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
22.22%Buy
44.44%Hold
22.22%Under-perform
11.11%Sell
Analyst Price Target
The average CLB stock price target is 27.61 with a high estimate of 34.00 and a low estimate of 21.50.
High34.00
Average27.61
Low21.50
Current 19.83
EPS
Actual
Estimate
0.050.100.150.20
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 409
Institutional Holdings: 61.41M
% Owned: 132.57%
Shares Outstanding: 46.32M
TypeInstitutionsShares
Increased
78
3.03M
New
42
1.32M
Decreased
39
1.06M
Sold Out
19
1.19M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Oil Related Services and Equipment
-0.01%
Oil & Gas Related Equipment and Services
+0.65%
Key Executives
Chairman - Supervisory/President/Chief Executive Officer/Chief Operating Officer/Director
Lawrence Bruno
Chief Financial Officer/Senior Vice President
Christopher Hill
Senior Vice President/General Counsel/Secretary
Mark Tattoli
Senior Vice President/Director of Investor Relations
Gwendolyn Gresham
Lead Director/Non-Executive Independent Director/Supervisory Board
Martha Carnes
Non-Executive Independent Director/Supervisory Board
Harvey Klingensmith
Non-Executive Independent Director/Supervisory Board
Michael Straughen
Non-Executive Independent Director/Supervisory Board
Kwaku Temeng
Non-Executive Independent Director/Supervisory Board
Monique van Dijken Eeuwijk
No Data
No Data
About CLB
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Webull offers kinds of Core Laboratories N.V. stock information, including NYSE:CLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CLB stock methods without spending real money on the virtual paper trading platform.